9 Comments
author
Oct 15, 2022·edited Oct 15, 2022Author

Wow, and that from 17 August 2022 in a cross-party, non-parliamentary enquiry? was there any political follow up?

Scale-Up and Post-Approval Change (SUPAC) stuff here.. yet to find the paragraph Dr. Rowe refers to

ttps://pharmaquest.weebly.com/uploads/9/9/4/2/9942916/10.pdf

australian stuff i will check out and surf from here:

https://www.tga.gov.au/resources/publication/publications/compounded-medicines-and-good-manufacturing-practice-gmp/interpretation-production-chapter-5

https://pharmaguidances.com/scale-up-and-postapproval-changes-supac-guidance-for-industry-a-regulatory-note-pharma/

bottom line:

there is no quality assurance that the manufacturing processes mimic the clinical trial processes.

the EMA lowered the bar to get the manufacturing processes going.

roughly 50$ of the RNA disappeared - v an 85% minimum.

the howbadismybatch.com data has probably revealed faults in the manufacturing quality.

foreign bodies/metallic substances discovered in some batches indicates that the PEG or lipid coating that is supposed to encapsulate the nano-particles has failed - because of semthing as basic as stirring a mixture differently.. (or maybe incorrect storage or transportation).

thanks very much for this.. much appreciated.

please do point me at further polirtical or scentific discovery/investigation on the topic.

I have no "in" with regulators or politicians. I am to contribute to the zeitgeist/narrative and inform those in the blogosphere that have influence.

Expand full comment

Thank Peter for this informative article. They are starting to roll out Moderna for healtcare workers in South Africa as part of Sisonke trial. So everyone who had one or two J&J's can now get a Moderna booster,and they call it the Sherpa leg of the Sisonke study. It truely blows my mind.

Expand full comment
author

Is the Moderna injection the original WuFlu targeted one, or the new bivalent one that has half (25mg) targeted at the original strain and the other (25mg) half at the BA1 Omicron strain (apparently clinically trialled by Moderna according to the UK government that authorized the new boster on 15 August 2022 - with indications from Moderna that it also is effective against Ba4 and Ba5.

EU Clinical trial data below:

https://eua.modernatx.com/covid19vaccine-eua/providers/clinical-trial-data

Study Type : Interventional (Clinical Trial)

Actual Enrollment : 5058 participants

Allocation: Non-Randomized

Intervention Model: Sequential Assignment

Masking: None (Open Label)

Primary Purpose: Prevention

Official Title: A Phase 2/3 Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 Variants

Actual Study Start Date : May 28, 2021

Estimated Primary Completion Date : April 30, 2023

Estimated Study Completion Date : April 30, 2023

Expand full comment

They call it Moderna mRNA 1273 Booster

Expand full comment

Peter,the do not say.

Expand full comment

There could be the end of someone's finger in one of these vaccine vials and it would be "no big deal". Green fungus could be crawling out of the vials and attaching itself to pharmacy workers (euthanasia specialists) and it would be an insignificant manufacturing issue that needs further investigation. People could be dropping dead before they leave the euthanasia center.... that's right this is already happening. Anyway.. you get my point. The CDC could recommend hacking children under five years old to death with machetes and it would be quickly accepted by the government and industry alike to help "stop the spread and keep us safe".

Expand full comment
Oct 14, 2022Liked by Peter Halligan

Another well written and informative article. Creates a lot more questions then answers about oversight of manufacturing processes, distribution and batch integrity.

I agree all the batches should be halted and recalled along with those who shamelessly pushed them. Then toss the whole “Lots” of them in the incinerator!

Expand full comment